← SynDRA
DARUSENTAN
SynDRA canonical compound SYN0001410 — structure-anchored drug synonym record
| Clinical phase | Phase 3 |
|---|
| Primary target(s) | EDNRA |
|---|
| Mechanism of action | endothelin receptor antagonist |
|---|
All known targets
Mechanisms of action (all sources)
- EDNRA ANTAGONIST
- Endothelin receptor ET-A antagonist
- EDNRB ANTAGONIST
- Endothelin receptor ET-B antagonist
- endothelin receptor antagonist
Drug classes
- Endothelin Receptor Antagonists
Cross-references
Synonyms
- LU-135252
- HMR-4005
- Endothelin antagonist, BASF
- LU-127043
- Lu 135252
- DTXCID2031453
- darusentanum
- RefChem:130971
- Darusentan [INN]
- MFCD00949063
- LU135252
- UNII-33JD57L6RW
- S-Darusentan?
- DARUSENTAN [MI]
- LU 127043
- DARUSENTAN [WHO-DD]
- SCHEMBL795084
- GTPL3508
- orb1301774
- GLXC-15448
- Tox21_113760
- BDBM50108202
- AKOS015994552
- EE-0200
- NCGC00253632-01
- AC-38120
- DA-52317
- HY-15404
- CAS-171714-84-4
- CS-0006252
- NS00069340
- T5458
- N16986
- BRD-K54863166-001-01-9
- داروسنتان
Look up DARUSENTAN in the interactive SynDRA portal →